Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
(Q40533297)
scientific article published on August 2004
scientific article published on August 2004
Language:
other details
description | scientific article published on August 2004 |
External Links
(P356) |
10.1016/J.YEXCR.2004.04.038
|
(P698) |
15265702
|